Drug Approval | August 16, 2022
Lupin receives approval from U.S. FDA for Meclizine Hydrochloride Tablets USP
Meclizine Hydrochloride Tablets had estimated annual sales of USD 29 million in the U.S.
Meclizine Hydrochloride Tablets had estimated annual sales of USD 29 million in the U.S.
ELCYS is the only FDA-approved cysteine hydrochloride injection on the market for use as an additive to amino acid solutions
QIAstat-Dx Viral Vesicular Panel tests for six pathogens that produce similar symptoms
The product will be manufactured at Lupin’s facility in Goa, India.
Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved in the US for children as young as five years of age
Company creates Younger T Cells for fighting cancer using its NR2F6 technology
MeitY will provide technical support for digitalisation of the Ayush Sector under the Ayush Grid project for a period of three years
Investment in response to increased demand for North American-based chemistry services
Pharmaceutical sales de-grew 18% YoY and stood at Rs. 224 crore whereas Crop Protection sales de-grew by 15% at Rs. 154 crore
AI-driven company anumana partnered with Novartis to drive the development of its electrocardiogram (ECG) AI algorithms to detect subclinical heart disease.
Subscribe To Our Newsletter & Stay Updated
